Quality Policy

Quality is integrated into all of our practices at PRU.

Our team of professionals interacts directly with clients to understand their specific requirements for their clinical study or related service.

As part of our commitment to continual improvement, we measure, assess and report quality data and seek ways to continually improve quality performance and results. According to industry best practices, our corrective and preventive action (CAPA) process ensures we investigate significant out-of-specification events, deviations and discrepancies, report the findings and conclusions of the investigation and implement and document corrective actions. We maintain preventative maintenance and calibration programs, as applicable, to ensure operational equipment is appropriately maintained and operating as defined.

Quality and regulatory affairs specialists oversee conformance with client requirements, U.S. Food and Drug Administration (FDA) regulations, MENA Region, European Union directives and other applicable international agencies’ regulations during each phase of the clinical trial process. Our experience and oversight ensures that our clinical, bioanalytical and related services comply with applicable Good Clinical Practices (GCP) and Good Laboratory Practices (GLP) .